Eledon Pharmaceuticals (ELDN) Capital Expenditures (2013 - 2016)
Eledon Pharmaceuticals (ELDN) posted Capital Expenditures of -$3000.0 for Q4 2016, down 250.0% on a QoQ basis from $2000.0 in Q3 2016, and down 101.39% year-over-year from $216000.0 in Q1 2016.
Eledon Pharmaceuticals (ELDN) Capital Expenditures (2013 - 2016) Analysis & Trends
Eledon Pharmaceuticals' Capital Expenditures history runs 4 years deep, the most recent figure standing at -$3000.0 for Q4 2016.
- Quarterly Capital Expenditures fell 101.39% year-over-year to -$3000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $9000.0 (down 98.41% YoY) and the FY2016 annual result came in at $9000.0, down 98.41% from the prior year.
- Capital Expenditures was -$3000.0 for Q4 2016 at Eledon Pharmaceuticals, down from $2000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $216000.0 in Q4 2015 and bottomed at -$7000.0 in Q2 2016.
- A 4-year average of $50250.0 and a median of $9500.0 in 2014 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2015 — Capital Expenditures soared 2957.14% — and 2016, when it tumbled 107.78%.
- Eledon Pharmaceuticals' Capital Expenditures stood at $4000.0 in 2013, then soared by 75.0% to $7000.0 in 2014, then surged by 2985.71% to $216000.0 in 2015, then tumbled by 101.39% to -$3000.0 in 2016.
- Business Quant data shows ELDN's Capital Expenditures at -$3000.0 in Q4 2016, $2000.0 in Q3 2016, and -$7000.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,079.99 Bn | 66,079.71 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 471.68 Bn | 466.89 Bn | 1.35 Bn | 43.25 Mn |
| 5 | Vertex Pharmaceuticals | 122.31 Bn | 115.06 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 70.24 Bn | 61.49 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 63.01 Bn | 63.01 Bn | - | - |
| 8 | Argenx Se | 56.02 Bn | 50.83 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.46 Bn | 34.45 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Eledon Pharmaceuticals | 404.17 Mn | 404.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -3,000.00 |
| Dec 31, 2016 | -3,000.00 |
| Sep 30, 2016 | 2,000.00 |
| Sep 30, 2016 | 2,000.00 |
| Jun 30, 2016 | -7,000.00 |
| Jun 30, 2016 | -7,000.00 |
| Mar 31, 2016 | 17,000.00 |
| Mar 31, 2016 | 17,000.00 |
| Dec 31, 2015 | 216,000.00 |
| Dec 31, 2015 | 216,000.00 |
| Sep 30, 2015 | 214,000.00 |
| Sep 30, 2015 | 214,000.00 |
| Jun 30, 2015 | 90,000.00 |
| Jun 30, 2015 | 90,000.00 |
| Mar 31, 2015 | 45,000.00 |
| Mar 31, 2015 | 45,000.00 |
| Sep 30, 2014 | 7,000.00 |
| Sep 30, 2014 | 7,000.00 |
| Jun 30, 2014 | 6,000.00 |
| Jun 30, 2014 | 6,000.00 |